Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use
Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said. Pakistan's health ministry has said the country was in process of speaking to different vaccine candidates.
Reuters | Islamabad | Updated: 19-01-2021 01:44 IST | Created: 19-01-2021 01:27 IST
Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said. The Drug Regulatory Authority Pakistan (DRAP) said the vaccine, manufactured by China National Pharmaceutical Group (SinoPharm), had been given emergency use approval (EUA).
The authority had approved AstraZeneca's vaccine, developed with Oxford University, for emergency use at the weekend. Pakistan's health ministry has said the country was in process of speaking to different vaccine candidates.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
- READ MORE ON:
- AstraZeneca
- Chinese
- Pakistan
- Oxford University
- SinoPharm
Advertisement
ALSO READ
'Pivotal moment' as Britain set to roll out AstraZeneca vaccine
AstraZeneca seeks approval of its COVID-19 vaccine in S.Korea -drug safety ministry
S.Korea reviews AstraZeneca COVID-19 vaccine, expands ban on gatherings
S.Korea reviews AstraZeneca COVID-19 vaccine, expands ban on gatherings
BRIEF-AstraZeneca Completes Atacand Divestment In More Than 70 Countries